Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Equioxx   
Auth. number : EU/2/08/083
INN : Firocoxib
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AH - Coxibs
Chemical substance: QM01AH90 - Firocoxib
(See WHO ATCvet Index)
Indication: Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.
Marketing Authorisation Holder: Merial
29 avenue Tony Garnier, F-69007 Lyon, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/06/2008 Centralised - Authorisation EMEA/V/C/142 (2008)3290 of 25/06/2008
21/09/2009 Centralised - Variation EMEA/V/C/142/II/2
27/11/2009 Centralised - Variation EMEA/V/C/142/IA/4
18/12/2009 Centralised - Variation EMEA/V/C/142/IB/3
22/12/2009 Centralised - Variation EMEA/V/C/142/X/1 (2009)10595 of 18/12/2009
12/03/2010 Centralised - Variation EMEA/V/C/142/IB/5/G
Updated with Decision(2010)7125 of 11/10/2010
13/10/2010 Centralised - Variation (2010)7125 of 11/10/2010
11/06/2013 Centralised - Renewal EMEA/V/C/142/R/9 (2013)3516 of 06/06/2013